MyStart Health vs Sprout Health

Choose MyStart Health if: You prioritize marginal cost savings ($120/year) through $10/month lower pricing ($217-267/month vs Sprout $227-277/month), accept essentially equivalent service quality and medical oversight, can self-manage nutrition and lifestyle modifications independently, and make purchasing decisions based primarily on pricing rather than meaningful service differentiation.

Choose Sprout if: You prefer established brand with slightly more market presence despite $10/month premium, accept near-identical service model and consultation quality as MyStart, or value marginal brand recognition over $120 annual savings. Service parity makes pricing primary differentiation—no meaningful quality advantage justifying premium.

Bottom line: MyStart Health and Sprout represent functionally equivalent budget-tier GLP-1 weight loss platforms competing in commoditized market segment with minimal differentiation. Both provide compound semaglutide ($217-277/month) through basic physician consultations, limited support infrastructure, and standard compounding pharmacy sourcing. MyStart edges on pricing ($120/year savings) while Sprout offers marginal brand establishment—otherwise indistinguishable service quality, medical oversight, medication sourcing, and patient outcomes. The $10/month difference represents primary competitive differentiation absent meaningful quality variations. Patients seeking complete behavioral support, specialized medical management, or premium pharmaceutical quality should consider higher-tier platforms (Eden, Ro Body) despite 30-50% cost premiums. Between these budget-tier options, choose based on pricing preference ($120/year savings vs marginal brand familiarity) rather than service quality differentiation that does not exist.